March 28, 2024 S&P 500 Soars 10% in Q1, Outstrips Bullish Forecasts
March 20, 2024 Fed Grapples With Rate Decision Amid Inflation Concerns
March 19, 2024 Bank of Japan Ends Era of Negative Rates
CashFlow Hunter On Pair Trading, 3M And Iris Energy
Apple: AI Strategy To Help Fight DOJ, Kickstart Growth
Nvidia Stock Priced As If It Will Deliver Us The Moon
March 15, 2024 6 Best Growth Stocks To Buy Now According to Metatrader 5
March 6, 2024 Navigating GBP Forecast: Mistakes To Avoid In Forex Trading
February 22, 2024 Trading Penny Stocks for Profit: Expert Insights and Practical Advice
February 15, 2024 Vanskelig å Få Refinansiering: Why Was Your Refinancing Loan Denied?
Canopy Growth (CGC) stock forecast for 2023
Updated: March 24, 2024 (11:30)
Sector: HealthcareThe share price of Canopy Growth Corp. (CGC) now
50/200 Day Moving Average: $3.968 / $5.46
This figure corresponds to the Average Price over the previous 50/200 days. For Canopy Growth stocks, the 50-day moving average is the resistance level today.
For Canopy Growth stocks, the 200-day moving average is the resistance level today.
Are you interested in Canopy Growth Corp. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Canopy Growth stock price in 2023. How much will one Canopy Growth share be worth in 2023? Is it worth taking profit / loss on CGC stock now or waiting? What are analysts' forecasts for Canopy Growth stock?
We forecast Canopy Growth stock performance using neural networks based on historical data on CGC stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account. This corporation stock prediction results are shown below and presented as a graph, table and text information.
Canopy Growth Corp. stock forecasts are adjusted once a day based on the closing price of the previous trading day.
The minimum target price for Canopy Growth analysts is $3.66. Today 200 Day Moving Average is the resistance level (5.46 $). 50 Day Moving Average is the resistance level (3.968 $).
Historical and forecast chart of Canopy Growth Corp. stock
The chart below shows the historical price of Canopy Growth stock and a prediction chart for the next year. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the CGC stock price can be found in the table below.
Sell or Buy Canopy Growth (CGC) stocks? Analytic Experts Forecasting...
The Canopy Growth Corporation, together with its subsidiaries, manufactures, distributes and markets cannabis for recreational and medical purposes, primarily in Canada, the United States, Germany and the United Kingdom. It operates in two segments: cannabis, hemp and other consumer products; and hinged rivers. The company’s products include dried cannabis flowers, oils and concentrates, and soft capsules. It offers its products under Tweed, Quatreau, Deep Space, Healing Spectrum, First and Free, Taiwan Dollar, It Works, BioSteel, CraftGrow DNA Genetics, Tokyo Smoke, Changed, Delicious Parcels, Van der Pop, and Beans and Bud brands. The company also provides growth capital and a strategic support platform that pursues investment opportunities in the global cannabis sector. Canopy Growth Corporation has a clinical research partnership with NEEKA Health Canada and the NHL Alumni Association to study the efficacy of CBD-based therapy in alleviating persistent post-exposure symptoms. As of February 14, 2020, she operated 28 cannabis retail stores called Tweed or Tokyo Smoke. The company was formerly known as Tweed Marijuana Inc. and changed its name to Canopy Growth Corporation in September 2015. Canopy Growth Corporation is headquartered in Smits Falls, Canada.
Canopy Growth (CGC) Forecast for 2023
Month | Target | Pes. | Opt. | Vol., % |
---|
Canopy Growth information and performance
1 HERSHEY DRIVE, SMITH FALLS, ON, CA
Market capitalization of the Canopy Growth Corp. is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of CGC shares in the company outstanding by the market price of one share.
EBITDA of Canopy Growth is earnings before interest, income tax and depreciation of assets.
P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit
Price/earnings to growth
Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.
Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.
EPS shows how much of the net profit is accounted for by the common share.
Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.
Forward P/E uses projections of future earnings instead of final numbers.
Enterprise Value (EV) /Revenue
The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).
Number of issued ordinary shares
Number of freely tradable shares
Shares Short Prior Month - the number of shares in short positions in the last month.
Canopy Growth price target for 2023 by month
Related stocks from Healthcare sector
All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.